Therapeutic potency of compound RMY-205 for pulmonary fibrosis induced by SARS-CoV-2 nucleocapsid protein

Pulmonary fibrosis is a typical sequela of coronavirus disease 2019 (COVID-19), which is linked with a poor prognosis for COVID-19 patients. However, the underlying mechanism of pulmonary fibrosis induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. Here, we demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhi-yuan, Ju, Cui-yu, Wu, Liu-zheng, Yan, Han, Hong, Wen-bin, Chen, Hang-zi, Yang, Peng-bo, Wang, Bao-Rui, Gou, Tong, Chen, Xiao-yan, Jiang, Zhi-hong, Wang, Wei-jia, Lin, Tianwei, Li, Fu-nan, Wu, Qiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990178/
https://www.ncbi.nlm.nih.gov/pubmed/36889311
http://dx.doi.org/10.1016/j.chembiol.2023.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990178/
https://www.ncbi.nlm.nih.gov/pubmed/36889311
http://dx.doi.org/10.1016/j.chembiol.2023.02.004

Ejemplares similares